191 related articles for article (PubMed ID: 27038932)
1. Expression and Prognostic Significance of p53 in Glioma Patients: A Meta-analysis.
Jin Y; Xiao W; Song T; Feng G; Dai Z
Neurochem Res; 2016 Jul; 41(7):1723-31. PubMed ID: 27038932
[TBL] [Abstract][Full Text] [Related]
2. RGS16 promotes glioma progression and serves as a prognostic factor.
Huang R; Li G; Zhao Z; Zeng F; Zhang K; Liu Y; Wang K; Hu H
CNS Neurosci Ther; 2020 Aug; 26(8):791-803. PubMed ID: 32319728
[TBL] [Abstract][Full Text] [Related]
3. Clinicopathological and Prognostic Significance of CD133 in Glioma Patients: A Meta-Analysis.
Han M; Guo L; Zhang Y; Huang B; Chen A; Chen W; Liu X; Sun S; Wang K; Liu A; Li X
Mol Neurobiol; 2016 Jan; 53(1):720-727. PubMed ID: 25589004
[TBL] [Abstract][Full Text] [Related]
4. A study on the correlation between STAT‑1 and mutant p53 expression in glioma.
Yang W; Wang H; Ju H; Dou C
Mol Med Rep; 2018 Jun; 17(6):7807-7812. PubMed ID: 29620180
[TBL] [Abstract][Full Text] [Related]
5. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
[TBL] [Abstract][Full Text] [Related]
6. Melanoma-associated antigen A2 is overexpressed in glioma and associated with poor prognosis in glioma patients.
Meng Q; Luo G; Liu B; Sun Y; Yan Z
Neoplasma; 2018; 65(4):604-609. PubMed ID: 30064232
[TBL] [Abstract][Full Text] [Related]
7. PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patients.
Draaisma K; Wijnenga MM; Weenink B; Gao Y; Smid M; Robe P; van den Bent MJ; French PJ
Acta Neuropathol Commun; 2015 Dec; 3():88. PubMed ID: 26699864
[TBL] [Abstract][Full Text] [Related]
8. Nestin Expression Is Associated with Poor Clinicopathological Features and Prognosis in Glioma Patients: an Association Study and Meta-analysis.
Lv D; Lu L; Hu Z; Fei Z; Liu M; Wei L; Xu J
Mol Neurobiol; 2017 Jan; 54(1):727-735. PubMed ID: 26768429
[TBL] [Abstract][Full Text] [Related]
9. Glioma tumor grade correlates with parkin depletion in mutant p53-linked tumors and results from loss of function of p53 transcriptional activity.
Viotti J; Duplan E; Caillava C; Condat J; Goiran T; Giordano C; Marie Y; Idbaih A; Delattre JY; Honnorat J; Checler F; Alves da Costa C
Oncogene; 2014 Apr; 33(14):1764-75. PubMed ID: 23644658
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-203 down-regulation is associated with unfavorable prognosis in human glioma.
He J; Deng Y; Yang G; Xie W
J Surg Oncol; 2013 Aug; 108(2):121-5. PubMed ID: 23813496
[TBL] [Abstract][Full Text] [Related]
11. Over-expression of wild-type p53-induced phosphatase 1 confers poor prognosis of patients with gliomas.
Liang C; Guo E; Lu S; Wang S; Kang C; Chang L; Liu L; Zhang G; Wu Z; Zhao Z; Ma S; Wang L; Jiao BH
Brain Res; 2012 Mar; 1444():65-75. PubMed ID: 22325093
[TBL] [Abstract][Full Text] [Related]
12. Up-regulation of microRNA-15b correlates with unfavorable prognosis and malignant progression of human glioma.
Pang C; Guan Y; Zhao K; Chen L; Bao Y; Cui R; Li G; Wang Y
Int J Clin Exp Pathol; 2015; 8(5):4943-52. PubMed ID: 26191187
[TBL] [Abstract][Full Text] [Related]
13. Increased expression of the 58-kD microspherule protein (MSP58) is correlated with poor prognosis in glioma patients.
Lin W; Li XM; Zhang J; Huang Y; Wang J; Zhang J; Jiang XF; Fei Z
Med Oncol; 2013 Dec; 30(4):677. PubMed ID: 23996240
[TBL] [Abstract][Full Text] [Related]
14. High Expression of Pirh2 is Associated with Poor Prognosis in Glioma.
Bao Y; Wu X; Yuan D; Shi W; Shi J
Cell Mol Neurobiol; 2017 Nov; 37(8):1501-1509. PubMed ID: 28258514
[TBL] [Abstract][Full Text] [Related]
15. p53 immunohistochemical positivity as a prognostic marker in intracranial tumours.
Soini Y; Niemelä A; Kamel D; Herva R; Bloigu R; Pääkkö P; Vähäkangas K
APMIS; 1994 Oct; 102(10):786-92. PubMed ID: 7826609
[TBL] [Abstract][Full Text] [Related]
16. Survival and low-grade glioma: the emergence of genetic information.
Claus EB; Walsh KM; Wiencke JK; Molinaro AM; Wiemels JL; Schildkraut JM; Bondy ML; Berger M; Jenkins R; Wrensch M
Neurosurg Focus; 2015 Jan; 38(1):E6. PubMed ID: 25552286
[TBL] [Abstract][Full Text] [Related]
17. miR-320a functions as a suppressor for gliomas by targeting SND1 and β-catenin, and predicts the prognosis of patients.
Li H; Yu L; Liu J; Bian X; Shi C; Sun C; Zhou X; Wen Y; Hua D; Zhao S; Ren L; An T; Luo W; Wang Q; Yu S
Oncotarget; 2017 Mar; 8(12):19723-19737. PubMed ID: 28160566
[TBL] [Abstract][Full Text] [Related]
18. Correlation of expression levels of ANXA2, PGAM1, and CALR with glioma grade and prognosis.
Gao H; Yu B; Yan Y; Shen J; Zhao S; Zhu J; Qin W; Gao Y
J Neurosurg; 2013 Apr; 118(4):846-53. PubMed ID: 23082878
[TBL] [Abstract][Full Text] [Related]
19. Expression of mutated isocitrate dehydrogenase-1 in gliomas is associated with p53 and EGFR expression.
Birner P; Toumangelova-Uzeir K; Natchev S; Guentchev M
Folia Neuropathol; 2011; 49(2):88-93. PubMed ID: 21845536
[TBL] [Abstract][Full Text] [Related]
20. Does a low frequency of P53 and Pgp expression in familial glioma compared to sporadic controls indicate biological differences?
Malmer B; Brännström T; Andersson U; Bergh K; Grönberg H; Henriksson R
Anticancer Res; 2002; 22(6C):3949-54. PubMed ID: 12553017
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]